Alterations in brain metabolism during the first year of HIV infection.
| Year: | 2011 | ||||||
| Type of Publication: | Article | Keywords: | Adult; Anti-Retroviral Agents, therapeutic use; Antigens, CD14, analysis; Aspartic Acid, analogs derivatives blood; Basal Ganglia, metabolism pathology virology; Choline, blood; Frontal Lobe, metabolism pathology virology; GPI-Linked Proteins, a | ||||
| Authors: |
|
||||||
| Journal: | J Neurovirol | Volume: | 17 | ||||
| Number: | 3 | Pages: | 220-229 | ||||
| Month: | June | ||||||
| Abstract: | |||||||
Migration of both uninfected and infected monocytes into the brain
during acute HIV infection likely initiates metabolic changes that
can be observed with magnetic resonance spectroscopy (MRS). Herein,
we measured changes in brain metabolism during the first year of
HIV infection and examined the relationship of these metabolite levels
to CD16+ monocyte populations measured in the blood. MRS was performed
on nine HIV+ subjects identified during acute HIV infection and nine
seronegative control subjects. HIV+ subjects were examined within
90 days of an indeterminate Western blot, then again 2 and 6 months
later, during early infection. Blood samples were collected for plasma
viral RNA and monocyte subset quantification. HIV+ subjects were
identified with acute viral ailment and did not display severe cognitive
deficits such as dementia or minor cognitive motor disorder. Changes
in lipid membrane metabolism (choline levels) in the frontal cortex
and white matter were observed during the initial year of HIV infection.
Greater numbers of CD16+ monocytes were associated with lower N-acetylaspartate
levels and higher choline levels in the brain. These results suggest
that HIV infection induces metabolic changes in the brain early during
infection and that these changes may be related to monocyte dynamics
in the periphery. |
|||||||
| Digital version | |||||||